Jennifer Nielsen Kahn

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

Diagnostic Mycology, Microbial Pathogens, Rare Laboratory +22

Acquired Echinocandin Resistance in a <i>Candida krusei</i> Isolate Due to Modification of Glucan Synthase

Jennifer Nielsen Kahn, Guillermo García‐Effrón, Ming‐Jo Hsu et al. · Antimicrobial Agents and Chemotherapy · 2007 · 118 citations · Full text

Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis

Kathleen N. McAllister, Laurent Bouillaut, Jennifer Nielsen Kahn et al. · Scientific Reports · 2017 · 102 citations · Full text

Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis

Paul A. Mann, Catherine A. McLellan, Sandra Koseoglu et al. · ACS Infectious Diseases · 2014 · 82 citations · Full text

Engineering, Gpi Anchor Pathway, Molecular Biology +16

PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural Products

Bo Jiang, Deming Xu, John Allocco et al. · Chemistry & Biology · 2008 · 82 citations

Antifungal Agent, Engineering, Medicine +9